Evaluating Novel and Relevant Information for Children's Health and Emotional Development

Search our Website

PUBLISHED RESEARCH

Aluminum

Mercury

Neurological

and Immune

Development

SIDS

Hepatitis B

Vaccine

Seizures

Vaccines

and Autism

Studies

Other

Research

1. Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure

 

2. Aluminum in the Central Nervous System

 

3. Aluminum and Vaccine Ingredients: What Do We Know? What Don’t We Know?

 

4. Aluminum Hydroxide Injections Lead to Motor Deficits and Motor Neuron Degeneration

 

5. Do Aluminum Vaccine Adjuvants Contribute to the Rising Prevalence of Autism?

 

6. Aluminum vaccine adjuvants: are they safe?

 

7. Protective effects of low-intensity pulsed ultrasound on aluminum-induced cerebral damage in Alzheimer’s disease rat model

 

8. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations

 

9. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration

 

10. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction

 

11. Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF)

 

12. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?

 

13. Aluminum adjuvant linked to gulf war illness induces motor neuron death in mice

 

14. Human exposure to aluminium

 

15. Aluminum Exposure at Human Dietary Levels for 60 Days Reaches a Threshold Sufficient to Promote Memory Impairment in Rats

 

16. Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity

 

17. The immunobiology of aluminium adjuvants: how do they really work?

 

18. Aluminum inclusion macrophagic myofasciitis: a recently identified condition

 

19. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

 

20. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome

 

21. Aluminum as an adjuvant in Crohn’s disease induction

 

22. Aluminum is a potential environmental factor for Crohn's disease induction: extended hypothesis

 

23. DNA released from dying host cells mediates aluminum adjuvant activity

 

24. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations

 

25. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity

 

26. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

 

27. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

 

28. Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response

 

29. Silica crystals and aluminum salts mediate NALP-3 inflammasome activation via phagosomal destabilization

 

30. Cutting Edge: Inflammasome activation by Alum and Alum’s adjuvant effect are mediated by NLRP3

 

31. Cognitive Deterioration and Associated Pathology Induced by Chronic Low-Level Aluminum Ingestion in a Translational Rat Model Provides an Explanation of Alzheimer's Disease, Tests for Susceptibility and Avenues for Treatment

 

32. Macrophagic myofasciitis: characterization and pathophysiology

 

33. Aluminum phagocytosis in quadriceps muscle following vaccination in children: relationship to macrophagic myofasciitis

 

34. Administration of aluminium to neonatal mice in vaccine relevant amounts is associated with adverse long term neurological outcomes.

 

35. Aluminum adjuvant linked to gulf war illness induces motor neuron death in mice.

 

36. Aluminum and Alzheimer’s disease: after a century of controversy, is there a plausible link?

 

37. Aluminium and breast cancer: Sources of exposure, tissue measurements and mechanisms of toxicological actions on breast biology Journal of Inorganic Biochemistry, 2013

 

38. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration

 

39. Aluminum Vaccine Adjuvants: Are They Safe?

 

40. Elevated brain aluminium and early onset Alzheimer’s disease in an individual occupationally exposed to aluminium: a case report.

 

41. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations.

 

42. Experimental Epilepsy in Monkey Following Multiple Intracerebral injections of Alumina Cream

 

43. Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity

 

44. Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?

 

45. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations

 

46. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration

 

 

 

 

 

1. B-Lymphocytes from a Population of Children with Autism Spectrum Disorder and Their Unaffected Siblings Exhibit Hypersensitivity to Thimerosal

 

2. Administration of Thimerosal to Infant Rats Increases Overflow of Glutamate and Aspartate in the Prefrontal Cortex: Protective Role of Dehydroepiandrosterone Sulfate

 

3. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal

 

4. A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders

 

5. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis

 

6. Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats

 

7. Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex- and strain-dependent effects

 

8. Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain

 

9. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines

 

10. Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate

 

11. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal

 

1. The Emerging Link Between Autoimmune Disorders and Neuropsychiatric Disease

 

2. Influence of pediatric vaccines on amygdala growth and opioid ligand binding in rhesus macaque infants: A pilot study

 

3. Primary Immunization of Premature Infants with Gestational Age <35 Weeks: Cardiorespiratory Complications and C-Reactive Protein Responses Associated with Administration of Single and Multiple Separate Vaccines Simultaneously

 

4. Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain.

 

5. Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex- and strain-dependent effects.

 

6. Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate.

 

7. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism.

 

8. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines.

 

9. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism.

 

10. In Harm’s Way: Toxic Threats to Child Development

 

11. Novel Roles for Immune Molecules in Neural Development: Implications for Neurodevelopmental Disorders

 

12. Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?

 

13. Primary Immunization of Premature Infants with Gestational Age <35 Weeks: Cardiorespiratory Complications and C-Reactive Protein Responses Associated with Administration of Single and Multiple Separate Vaccines Simultaneously

 

14. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.

 

15. Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats.

 

16. Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex- and strain-dependent effects.

 

17. Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate.

 

18. A possible central mechanism in autism spectrum disorders, part 1.

 

19. A possible central mechanism in autism spectrum disorders, part 2: immunoexcitotoxicity.

 

20. Association between vaccination and Guillain-Barré syndrome

 

21. Human papillomavirus vaccine and systemic lupus erythematosus

 

22. Autoimmune (Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA) - Animal Models as a Proof of Concept

 

23. Hepatitis B Vaccination and Undifferentiated Connective Tissue Disease: Another Brick in the Wall of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA)

 

24. Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice.

 

25. Vaccine-induced Autoimmunity

 

26. ‘ASIA’ - Autoimmune/inflammatory syndrome induced by adjuvants

 

27. The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’

 

28. Chronic fatigue syndrome with autoantibodies--the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant.

 

29. The Common Immunogenic Etiology of Chronic Fatigue Syndrome: From Infections to Vaccines via Adjuvants to the ASIA Syndrome

 

30. Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination

 

31. A Study of Molecular Mimicry and Immunological Cross-reactivity between Hepatitis B Surface Antigen and Myelin Mimics

 

32. Comparison of tissue reactions produced by Haemophilus pleuropneumoniae vaccines made with six different adjuvants in swine.

 

33. Induction of autoimmunity by pristane and other naturally-occurring hydrocarbons

 

34. Manifestations of systemic autoimmunity in vaccinated salmon

 

35. Polyclonal hypergammaglobulinemia and autoantibody production induced by vaccination in farmed Atlantic salmon.

 

36. Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome.

 

37. When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA).

 

38. Vaccine model of antiphospholipid syndrome induced by tetanus vaccine.

 

39. The sick building syndrome as a part of the autoimmune (auto-inflammatory) syndrome induced by adjuvants.

 

40. Gulf War syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA).

 

41. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study

 

42. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas.

 

43. Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.

 

44. Postural tachycardia syndrome following human papillomavirus vaccination.

 

45. Guillain-Barré syndrome following hepatitis B vaccination

 

46. Pemphigus following hepatitis B vaccination--coincidence or causality?

 

47. Infection, vaccines and other environmental triggers of autoimmunity.

 

48. Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle.

 

49. Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence?

 

50. Post-vaccination encephalomyelitis: Literature review and illustrative case

 

51. Interindividual variations in the efficacy and toxicity of vaccines.

 

52. Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases.

 

53. Infection and vaccination in chronic fatigue syndrome: myth or reality?

 

54. Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination.

 

55. Post-influenza vaccination vasculitides: a possible new entity.

 

56. Vaccination, atherosclerosis and systemic lupus erythematosus.

 

57. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine.

 

58. Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment.

 

59. Medulloblastoma in childhood: an epidemiological study.

 

60. Poliovirus Vaccination during Pregnancy, Maternal Seroconversion to Simian Virus 40, and Risk of Childhood Cancer.

 

61. Simian Virus 40 Infection of Humans.

 

62. Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

 

64. Infant Gets Measles from the Vaccine

 

65. Measles Outbreak Traced Back to Fully Vaccinated

 

67. Smallpox Vaccine Shedding

 

68. Polio Outbreak Sparked by [Live Virus] Vaccine

 

69. Child Survives Smallpox Vaccine Reaction (Eczema Vaccinium)

 

70. Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate.

 

71. Comparison of Blood and Brain Mercury Levels in Infant Monkeys Exposed to Methylmercury or Vaccines Containing Thimerosal.

 

72. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines.

 

73. Lasting neuropathological changes in rat brain after intermittent neonatal administration of thimerosal.

 

74. Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex and strain dependent effects.

 

75. Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain.

 

76. Neurodevelopmental disorders following thimerosal containing childhood immunizations.

 

77. Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats.

 

78. Thimerosal induces neuronal cell apoptosis by causing cytochrome c and apoptosisinducing factor release from mitochondria.

 

79. Thimerosal Exposure and the Role of Sulfation Chemistry and Thiol Availability in Autism.

 

80. Smallpox Vaccine Shedding

 

81. Polio Outbreak Sparked by [Live Virus] Vaccine

 

82. Child Survives Smallpox Vaccine Reaction (Eczema Vaccinium)

 

83. Sibling Transmission of Vaccine-Derived Rotavirus (RotaTeq) Associated With Rotavirus Gastroenteritis

 

84. Chicken Pox Vaccine Causes Shedding

 

85. Measles Outbreak in IL High School with 100% Vaccination Rate

 

86. Outbreak of Measles Among Persons with Prior Evidence of Immunity

 

87. Canadian Child gets Measles from Vaccine

 

88. “10 days after vaccination, developed vaccine measles which was clinically indistinguishable from the natural disease”

 

89. Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons.

 

90. Outbreak of Measles Among Persons With Prior Evidence of Immunity

 

91. Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus. Vaccine, 2006

 

92. Transmission of mumps virus from mumps vaccinated individuals to close contacts Vaccine, 2011

 

93. Mumps vaccine virus transmission.

 

94. Comparison of the Safety, Vaccine Virus Shedding, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-Adapted, Administered to Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected.

 

95. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine.

 

96. Rotavirus vaccines: viral shedding and risk of transmission.

 

97. Sibling Transmission of Vaccine-Derived Rotavirus (RotaTeq) Associated With Rotavirus Gastroenteritis.

 

98. Pertussis Infection in Fully Vaccinated Children in Day-Care Centers, Israel. Emerging Infectious Diseases.

 

99. Detection of measles virus RNA in urine specimens from vaccine recipients.

 

100. The Case against Universal Varicella Vaccination International.

 

101. Review of the United States universal varicella vaccination program.

 

102. Medulloblastoma in childhood: an epidemiological study.

 

103. Poliovirus Vaccination during Pregnancy, Maternal Seroconversion to Simian Virus 40, and Risk of Childhood Cancer.

 

104. Simian Virus 40 Infection of Humans.

 

105. Live Virus Vaccines and Vaccine SheddingSibling Transmission of Vaccine-Derived Rotavirus (RotaTeq) Associated With Rotavirus Gastroenteritis.

 

106. Cause of vaccine associated measles five weeks post immunization.

 

107. The Case against Universal Varicella Vaccination International.

 

108. Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database.

 

109. Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature.

 

110. Human papillomavirus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.

 

111. Association between type 1 diabetes and Hib vaccine.

 

112. A causal association between Haemophilus influenzae type b (Hib) vaccine and diabetes.

 

113. 150+ deaths reported to VAERS as of June 2017

 

114. A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines.

 

 

 

1. Infant mortality rates regressed against number of vaccine doses routinely given: Is there a biochemical or synergistic toxicity?

 

2. The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997

 

3. Sudden infant death syndrome and diphtheria-tetanus-pertussis-poliomyelitis vaccination status

 

4. Revisiting the possibility of serious adverse events from the whole cell pertussis vaccine: were metabolically vulnerable children at risk?

 

5. Possible temporal association between diphtheria-tetanus toxoid-pertussis vaccination and sudden infant death syndrome.

 

6. Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010.

 

7. Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome.

 

8. Sudden infant death following hexavalent vaccination: a neuropathologic study.

 

9. Beta-tryptase and quantitative mast-cell increase in a sudden infant death following hexavalent immunization.

 

10. Hepatitis B vaccination has been linked to anaphylactic shock and death in infants.

 

11. In 1985 twin boys simultaneously succumbed to sudden unexpected deaths two to three hours after vaccination with diphtheria, tetanus, and pertussis vaccine (DTP).

 

12. Sudden infant death syndrome (SIDS) shortly after hexavalent vaccination has been reported.

 

13. DTP vaccination may contribute to urinary tract disease and sudden infant death syndrome.

 

14. A well researched article on SIDS and vaccines:

 

16. This study showed a 6x increase in febrile seizures within 24 hours of receiving DTP and a three-fold increase of febrile seizures after the MMR (manifesting 8-14 days post-vaccination).

 

17. Premature babies have higher risk of sepsis and cardiorespiratory events after vaccination in the NICU

This study reports a significant increase in the incidence of sepsis evaluations, respiratory support, and intubation after immunization of premature babies in the NICU. The findings of this study confirm what a number of other retrospective studies have found—that low birth weight infants appear to have an increase in cardiorespiratory events and sepsis evaluations after vaccination. The main strength of this study and what makes it unique is its large sample size of infants born at less than 28 weeks gestation.

 

1. This study showed a 6x increase in febrile seizures within 24 hours of receiving DTP and a three-fold increase of febrile seizures after the MMR (manifesting 8-14 days post-vaccination).

 

2. The Risk of Seizures After Receipt of Whole-Cell Pertussis or Measles, Mumps, and Rubella Vaccine Epilepsy Curr. 2002 Jan

 

3. Vaccination Triggers, Rather Than Causes, Seizures Epilepsy Curr. 2015 Nov-Dec

 

4. Etiologies for Seizures Around the Time of Vaccination Pediatrics, September 2014

 

5. Febrile Seizure Risk After Vaccination in Children 6 to 23 Months Pediatrics, June 2016.

 

6. Identification of seizures among adults and children following influenza vaccination using health insurance claims data. Vaccine. 2013 Dec 5

 

7. Systematic review of fever, febrile convulsions and serious adverse events following administration of inactivated trivalent influenza vaccines in children.Euro Surveill. 2015 Jun 18

 

8. Most Vaccination-Onset Epilepsy Has Genetic, Structural Cause September 24, 2014

 

9. Risk of febrile seizure after measles-mumps-rubella-varicella vaccine: A systematic review and meta-analysis. Vaccine. 2015 Jul

 

10. Vaccination and occurrence of seizures in SCN1A mutation-positive patients: a multicenter Italian study..Pediatr Neurol. 2014 Mar

 

11. Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program. Pediatrics. 1998 Mar

 

12. Common variants associated with general and MMR vaccine-related febrile seizures. Nat Genet. 2014 Dec

 

13. Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine. 2015 Mar

 

14. Breakthrough: why MMR vaccine can give children febrile seizures November 11, 2014

 

 

 

 

 

 

1. A Positive Association found between Autism Prevalence and Childhood Vaccination uptake across the U.S. Population.

 

2. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism.

 

3. Autism: A Brain Disorder, or A Disorder That Affects the Brain?

 

4. B-Lymphocytes from a Population of Children with Autism Spectrum Disorder and Their Unaffected Siblings Exhibit Hypersensitivity to Thimerosal.

 

5. Blood Levels of Mercury Are Related to Diagnosis of Autism.

 

6. California’s Autism Increase Not Due to Better Counting, Diagnosis.

 

7. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism.

 

8. Developmental Regression and Mitochondrial Dysfunction in a Child With Autism

 

9. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?

 

10. Elevated levels of measles antibodies in children with autism.

 

11. Emperical Data Confirms Autism Symptoms Related to Aluminum and Acetominophen.

 

12. Environmental mercury release, special education rates, and autism disorder.

 

13. Evidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism.

 

14. Hepatitis B vaccination of male neonates and autism diagnosis.

 

15. Hypothesis: conjugate vaccines may predispose children to autism spectrum disorders.

 

16. A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.

 

17. A positive association found between autism prevalence and childhood vaccination uptake across the U.S. population.

 

18. Commentary–Controversies surrounding mercury in vaccines: autism denial as impediment to universal immunisation.

 

19. Methodological issues and evidence of malfeasance in research purporting to show thimerosal in vaccines is safe.

 

20. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism.

 

21. Hepatitis B vaccination of male neonates and autism diagnosis.

 

22. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?

 

23. What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?

 

24. A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders.

 

25. A comprehensive review of mercury provoked autism.

 

26. Thimerosal Exposure and the Role of Sulfation Chemistry and Thiol Availability in Autism.

 

27. B-Lymphocytes from a Population of Children with Autism Spectrum Disorder and Their Unaffected Siblings Exhibit Hypersensitivity to Thimerosal.

 

28. Impact of environmental factors on the prevalence of autistic disorder after 1979.

 

29. Measles-mumps-rubella vaccination timing and autism among young African American boys: a reanalysis of CDC data.

 

30. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism.

 

31. Neuroglial Activation and Neuro-inflammation in the Brain of Patients with Autism.

 

32. Oxidative Stress in Autism: Elevated Cerebellar 3-nitrotyrosine Levels American.

 

33. Porphyrinuria in childhood autistic disorder: Implications for environmental toxicity.

 

34. Possible Immunological Disorders in Autism: Concomitant Autoimmunity and Immune Tolerance.

 

35. Reduced levels of mercury in first baby haircuts of autistic children.

 

36. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism.

 

37. Sorting out the spinning of autism: heavy metals and the question of incidence.

 

38. Vaccines and Regressive Autism North American Journal of Medical Sciences.

 

39. Validation of the Phenomenon of Autistic Regression Using Home Videotapes

 

40. What’s going on? The question of time trends in autism.

 

41. What is regressive autism and why does it occur? Is it the consequence of multi systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?

 

42. News Report: CDC Admits Vaccines Can in Some Cases Trigger Autism.

 

43. News Report: Where are The Autistic Amish?

 

44. Theoretical aspects of autism: causes–a review.

 

45. Conjugate vaccines and autism.

 

46. Autism: a novel form of mercury poisoning.

 

47. A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders.

 

48. Hypothesis: conjugate vaccines may predispose children to autism spectrum disorders.

 

49. The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity.

 

50. Reduced levels of mercury in first baby haircuts of autistic children.

 

51. Cultured lymphocytes from autistic children and non-autistic siblings up-regulate heat shock protein RNA in response to thimerosal challenge.

 

52. A possible central mechanism in autism spectrum disorders, part 1.

 

53. The role of mercury in the pathogenesis of autism.

 

54. Transcriptomic analyses of neurotoxic effects in mouse brain after intermittent neonatal administration of thimerosal.

 

55. A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.

 

 

Miller's Review of Critical Vaccine Studies: 400 Important Scientific Papers Summarized for Parents and Researchers

 

Neil Z. Miller

In light of the discovery of Autoimmune Syndrome Induced by Adjuvants, or ASIA, Vaccines and Autoimmunity explores the role of adjuvants – specifically aluminum in different vaccines – and how they can induce diverse autoimmune clinical manifestations in genetically prone individuals.